Brief: Immunome Reports Q3 Financial Results
14/11/2022 18:16
Nov 14 (Reuters) - Immunome Inc IMNM.O :
* IMMUNOME REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* IMMUNOME INC - AS OF SEPTEMBER 30, 2022, CASH AND CASH
EQUIVALENTS TOTALED $27.1 MILLION
* IMMUNOME INC - QTRLY NET LOSS PER SHARE $0.75
Source text for Eikon: ID:nBw8fZcz6a
Further company coverage: IMNM.O
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage